The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

Researchers have identified genetic variants in the FOXP4 gene that significantly increase the risk of developing long COVID, ...

Plus, new clues about the rise in colorectal cancer rates in young adults. You are reading our weekly Well+Being newsletter.

The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...